Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Melanoma × Adalimumab × Clear all

Sponsor

Conditions

Arthritis, Rheumatoid 5 Psoriasis 2 Spondylitis, Ankylosing 1 Sarcoidosis 1 Plaque Psoriasis 1 Nephrotic Syndrome 1 Nephrosis, Lipoid 1 Mucopolysaccharidosis VI 1 Mucopolysaccharidosis II 1 Mucopolysaccharidosis I 1 Mucopolysaccharidoses 1 Macular dystrophy, corneal type 1 1 Kidney Diseases 1 Inflammation 1 Glomerulosclerosis, Focal Segmental 1 Dupuytren Contracture 1 Crohn Disease 1 Colitis, Ulcerative 1 Arthritis, Psoriatic 1

Interventions

Ipilimumab 79 pembrolizumab 71 Nivolumab 68 aldesleukin 46 Cyclophosphamide 44 Interleukin-2 33 fludarabine phosphate 30 Vemurafenib 29 Dacarbazine 28 trametinib 25 fludarabine 25 dabrafenib 25 Temozolomide 21 Bevacizumab 15 Radiosurgery 14 binimetinib 12 Paclitaxel 12 Introns 12 Interferon alpha-2 12 Carboplatin 11 CTLA-4 Antigen 11 peginterferon alfa-2b 9 montanide ISA 51 9 encorafenib 9 cobimetinib 9 Radiotherapy 9 talimogene laherparepvec 8 atezolizumab 8 Sorafenib 8 spartalizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡